Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
G-CSF is not necessary to maintain over 99% dose-intensity with ABVD in the treatment of Hodgkin lymphoma: low toxicity and excellent outcomes in a 10-year analysis.
Evens AM, Cilley J, Ortiz T, Gounder M, Hou N, Rademaker A, Miyata S, Catsaros K, Augustyniak C, Bennett CL, Tallman MS, Variakojis D, Winter JN, Gordon LI. Evens AM, et al. Br J Haematol. 2007 Jun;137(6):545-52. doi: 10.1111/j.1365-2141.2007.06598.x. Epub 2007 Apr 24. Br J Haematol. 2007. PMID: 17459049 Free article.
Bortezomib may be safely combined with Y-90-ibritumomab tiuxetan in patients with relapsed/refractory follicular non-Hodgkin lymphoma: a phase I trial of combined induction therapy and bortezomib consolidation.
Roy R, Evens AM, Patton D, Gallot L, Larson A, Rademaker A, Cilley J, Spies S, Variakojis D, Gordon LI, Winter JN. Roy R, et al. Leuk Lymphoma. 2013 Mar;54(3):497-502. doi: 10.3109/10428194.2012.722215. Epub 2012 Sep 11. Leuk Lymphoma. 2013. PMID: 22906230 Clinical Trial.
Adjuvant therapy for colon cancer.
Cilley J, Mulcahy MF. Cilley J, et al. Curr Oncol Rep. 2006 May;8(3):161-6. doi: 10.1007/s11912-006-0015-7. Curr Oncol Rep. 2006. PMID: 16618379 Review.
Bevacizumab in the treatment of colorectal cancer.
Cilley JC, Barfi K, Benson AB 3rd, Mulcahy MF. Cilley JC, et al. Expert Opin Biol Ther. 2007 May;7(5):739-49. doi: 10.1517/14712598.7.5.739. Expert Opin Biol Ther. 2007. PMID: 17477810 Review.